Taysha Gene Therapies, Inc. (TSHA): Shares Outstanding

Annual figures by period end, from SEC filings.

285.05M
As of 2025-12-31
325.30M
As of 2026-06-30
2019-12-31: 10.89M2020-12-31: 37.76M2021-12-31: 38.47M2022-12-31: 63.21M2023-12-31: 186.96M2024-12-31: 204.94M2025-12-31: 285.05M285.05M
2019-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-31285.05M+39.1%2026-03-19, Balance as of period end
2024-12-31204.94M+9.6%2026-03-19, Balance as of period end
2023-12-31186.96Mn/c2025-02-26, Balance as of period end
2022-12-3163.21M+64.3%2024-03-19, Balance as of period end
2021-12-3138.47M+1.9%2023-03-28, Balance as of period end
2020-12-3137.76M+246.6%2022-03-31, Balance as of period end
2019-12-3110.89Mn/a2021-03-03, Balance as of period end